Peripheral neuropathy decisions — 2006

The veteran's claims for higher ratings for diabetes mellitus, type II and peripheral neuropathy of the lower extremities are being remanded due to incomplete notification under the VCAA and need for additional medical examination.

The veteran's peripheral neuropathy is being remanded for further development, including a VA examination and notification under the VCAA. The case will be returned to the Board if necessary.

The Board has determined that the veteran's claims for increased evaluations for type II diabetes mellitus, clinical neuropathy of the right lower extremity, and clinical neuropathy of the left lower extremity are denied as they do not meet the criteria for a higher evaluation under applicable rating codes.

The veteran's diabetes mellitus and diabetic peripheral neuropathy are not service-connected due to lack of in-country exposure to Agent Orange during his military service.

The veteran's appeal is remanded for further development, including obtaining medical records and providing proper VCAA notice.

The Board has remanded the case for further development, including a VA examination to determine if the veteran has peripheral neuropathy and PTSD related to his service.

The Board has denied the veteran's claims of service connection for acute and subacute peripheral neuropathy and peripheral neuropathy as there is no evidence that these conditions were incurred in or aggravated by his military service.

The Board has determined that the veteran's service-connected polyneuropathy of each extremity is currently rated as 10 percent disabling, which is the maximum schedular rating available under applicable diagnostic codes. The claim for increased ratings is therefore denied.

The veteran does not have peripheral neuropathy of his hands, arms, feet, or legs that is the result of disease or injury incurred in or aggravated during active military service. The Board finds that the veteran's claim for service connection must be denied.

The Board denied the appellant's claims of service connection for myasthenia gravis, sleep apnea, diabetes mellitus type II and peripheral neuropathy. The evidence did not show exposure to Agent Orange or any other herbicide agent during service.

The Board granted an increased rating to 30 percent for the veteran's service-connected left leg disabilities, including neuropathy and fracture residuals. The effective date is not specified.

The Board found that the veteran's peripheral neuropathy is not etiologically related to his service-connected dermatitis or treatment for it.

The veteran's appeal has been dismissed as the appellant withdrew their appeal prior to a decision being made.

The Board has reopened the veteran's claims for service connection for headaches, chronic ear infections, neuropathy, prostate disorder, stomach disorder with diarrhea and pain, and GERD. The appeals are granted.

The Board has remanded the case due to outstanding VA treatment records and need for clarification regarding the nature of the veteran's peripheral neuropathy and erectile dysfunction, as well as their relationship to service-connected diabetes mellitus.

The Board found that the veteran's claimed acute and subacute peripheral neuropathy is not related to service or herbicide exposure, and thus denied his claim.

The Board has denied the veteran's claims for increased disability ratings for his service-connected peripheral neuropathy of the upper and lower extremities, finding that the evidence does not meet the criteria for a higher rating.

The veteran's service-connected disabilities, including arteriosclerotic heart disease and peripheral neuropathy of multiple extremities, render him unable to secure or follow a substantially gainful occupation.

The veteran's service-connected disabilities do not meet the criteria for VA financial assistance in purchasing an automobile and adaptive equipment or adaptive equipment only.

The Board has remanded the case due to the need for a VA examination and further development of evidence, including notification regarding service connection for cervical and lumbar degenerative disc disease with spondylosis secondary to service-connected cerebral palsy.